TD Cowen analyst Ritu Baral maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price target of ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

The rating changes comes after Wednesday’s release of “in-line and mixed” fourth-quarter 2024 financial results, which saw it ...

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...

We recently compiled a list of the 10 Best Performing Fintech Stocks to Buy According to Analysts. In this article, we are ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target ...

Calumet downgraded at TD Cowen, saying the market has more fully accounted for near-term risks both for the Montana Renewable ...

MYT Netherlands (NYSE:MYTE) shares rose more than 5% intra-day today after TD Cowen analysts upgraded the stock from Hold to ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.